Evidence map›Paper›PMID 25855196›Full record

ArticleThe Journal of neuroscience : the official journal of the Society for Neuroscience2015

Central 5-HT neurotransmission modulates weight loss following gastric bypass surgery in obese individuals.

M E Haahr, D L Hansen, P M Fisher, C Svarer, D S Stenbæk, K Madsen, J Madsen, J J Holst, W F C Baaré, L Hojgaard and 2 more

Open access · bronzeAbstract read
In one paragraph

Article in The Journal of neuroscience : the official journal of the Society for Neuroscience, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed, 2 pooled it
5.3field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed, 2 syntheses or guidelines pooled it, 40 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Central noradrenaline transporter availability in highly obese, non-depressed individuals.European journal of nuclear medicine and molecular imaging · 2017
    Trial
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Review
  13. Article
  14. Review
  15. Review
  16. Article
  17. Article
  18. Noradrenaline transporter availability on [European journal of nuclear medicine and molecular imaging · 2018
    Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 4 institutions in 1 country.

M E HaahrNeurobiology Research Unit, Rigshospitalet, 2100 Copenhagen, Denmark, Center for Integrated Molecular Brain Imaging, Rigshospitalet and University of Copenhagen, 2100 Copenhagen, Denmark.
D L HansenDepartment of Endocrinology and.
P M FisherNeurobiology Research Unit, Rigshospitalet, 2100 Copenhagen, Denmark, Center for Integrated Molecular Brain Imaging, Rigshospitalet and University of Copenhagen, 2100 Copenhagen, Denmark.
C SvarerNeurobiology Research Unit, Rigshospitalet, 2100 Copenhagen, Denmark, Center for Integrated Molecular Brain Imaging, Rigshospitalet and University of Copenhagen, 2100 Copenhagen, Denmark.
D S StenbækNeurobiology Research Unit, Rigshospitalet, 2100 Copenhagen, Denmark, Center for Integrated Molecular Brain Imaging, Rigshospitalet and University of Copenhagen, 2100 Copenhagen, Denmark.
K MadsenNeurobiology Research Unit, Rigshospitalet, 2100 Copenhagen, Denmark, Center for Integrated Molecular Brain Imaging, Rigshospitalet and University of Copenhagen, 2100 Copenhagen, Denmark.
J MadsenPET and Cyclotron Unit, Rigshospitalet and University of Copenhagen, 2100 Copenhagen, Denmark, and.
J J HolstThe NNF Center for Basic Metabolic Research, Department of Biomedical Sciences, University of Copenhagen, 2100 Copenhagen, Denmark.
W F C BaaréCenter for Integrated Molecular Brain Imaging, Rigshospitalet and University of Copenhagen, 2100 Copenhagen, Denmark, Danish Research Centre for Magnetic Resonance, Hvidovre Hospital, 2650 Hvidovre, Denmark.
L HojgaardPET and Cyclotron Unit, Rigshospitalet and University of Copenhagen, 2100 Copenhagen, Denmark, and.
T AlmdalSteno Diabetes Center, 2820 Gentofte, Denmark.
G M KnudsenNeurobiology Research Unit, Rigshospitalet, 2100 Copenhagen, Denmark, Center for Integrated Molecular Brain Imaging, Rigshospitalet and University of Copenhagen, 2100 Copenhagen, Denmark, gmk@nru.dk.
University of Copenhagen · DKRigshospitalet · DKHvidovre Hospital · DKSteno Diabetes Center · DK

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The cerebral serotonin (5-HT) system shows distinct differences in obesity compared with the lean state. Here, it was investigated whether serotonergic neurotransmission in obesity is a stable trait or changes in association with weight loss induced by Roux-in-Y gastric bypass (RYGB) surgery. In vivo cerebral 5-HT2A receptor and 5-HT transporter binding was determined by positron emission tomography in 21 obese [four men; body mass index (BMI), 40.1 ± 4.1 kg/m(2)] and 10 lean (three men; BMI, 24.6 ± 1.5 kg/m(2)) individuals. Fourteen obese individuals were re-examined after RYGB surgery. First, it was confirmed that obese individuals have higher cerebral 5-HT2A receptor binding than lean individuals. Importantly, we found that higher presurgical 5-HT2A receptor binding predicted greater weight loss after RYGB and that the change in 5-HT2A receptor and 5-HT transporter binding correlated with weight loss after RYGB. The changes in the 5-HT neurotransmission before and after RYGB are in accordance with a model wherein the cerebral extracellular 5-HT level modulates the regulation of body weight. Our findings support that the cerebral 5-HT system contributes both to establish the obese condition and to regulate the body weight in response to RYGB.

Indexed as

AdultBody Mass IndexBrainBrain MappingCase-Control StudiesDenmarkFemaleGastric BypassGlucagon-Like Peptide 1HumansKetanserinMaleMiddle AgedObesityProtein BindingRadionuclide ImagingaltanserinGlucagon-Like Peptide 1KetanserinReceptor, Serotonin, 5-HT2ASerotonin Antagonists5-HT5-HT2A receptor5-HT transporterbariatric surgerypositron emission tomography

Identifiers

PMID25855196
PMCPMC6605315
OpenAlexW2004554448

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.